Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

How will genomics be applied to patient therapy in future?

Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015

Inside cancer - public lecture

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
29 Apr 2015

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma

Dr Evan Alley - University of Pennsylvania, Philadelphia, USA
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma ( Dr Evan Alley - University of Pennsylvania, Philadelphia, USA )
29 Apr 2015

Chk1 inhibition combined with standard dose gemcitabine may be safe and effective

Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Chk1 inhibition combined with standard dose gemcitabine may be safe and effective ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
29 Apr 2015

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
27 Apr 2015

BRAF 'behind the scenes' in melanoma: A scientific story of discovery

Prof Richard Marais - Cancer Research UK Manchester Institute, Manchester, UK
BRAF 'behind the scenes' in melanoma: A scientific story of discovery ( Prof Richard Marais - Cancer Research UK Manchester Institute, Manchester, UK )
19 Mar 2015

Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice

Dr Bart Neyns - Universitair Ziekenhuis Brussels, Brussels, Belgium
Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice ( Dr Bart Neyns - Universitair Ziekenhuis Brussels, Brussels, Belgium )
19 Mar 2015

Targeting CDK pathways in cancer treatment

Dr Geoffrey Shapiro - Dana Farber Cancer Institute, Boston, USA
Targeting CDK pathways in cancer treatment ( Dr Geoffrey Shapiro - Dana Farber Cancer Institute, Boston, USA )
11 Mar 2015

DNA repair inhibitors to overcome drug resistance

Dr Ruth Plummer - Newcastle University, Newcastle, UK
DNA repair inhibitors to overcome drug resistance ( Dr Ruth Plummer - Newcastle University, Newcastle, UK )
11 Mar 2015

Refining the role of PARP inhibitors in targeted anticancer therapy

Prof Yves Pommier - National Cancer Institute, Bethesda, USA
Refining the role of PARP inhibitors in targeted anticancer therapy ( Prof Yves Pommier -  National Cancer Institute, Bethesda, USA )
11 Mar 2015

Developments in immunotherapy

Prof Lillian Siu - University Health Network, Toronto, Canada
Developments in immunotherapy ( Prof Lillian Siu - University Health Network, Toronto, Canada )
11 Mar 2015

Discovering selective anticancer drugs: succeeding slowly is better than failing fast

Professor Hilary Calvert - UCL Cancer Institute, London, UK
Discovering selective anticancer drugs: succeeding slowly is better than failing fast ( Professor Hilary Calvert - UCL Cancer Institute, London, UK )
10 Mar 2015